|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.965 USD | -28.03% |
|
-27.46% | -39.35% |
| 02:33pm | Top Premarket Decliners | MT |
| 02:27pm | Exchange-Traded Funds Mixed, Equity Futures Higher Pre-Bell Tuesday Ahead of Powell Speech | MT |
Akoya Biosciences, Inc. provided revenue guidance for the full year 2024. or the period, the company expects revenue guidance range of $114.0-118.0 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -39.35% | 203M | |
| +11.69% | 225B | |
| +10.40% | 186B | |
| +12.68% | 135B | |
| +25.53% | 107B | |
| +0.72% | 63.56B | |
| +5.62% | 51.32B | |
| +12.22% | 51.04B | |
| +8.38% | 43.3B | |
| +4.47% | 36.99B |
AKOYA BIOSCIENCES, INC. 
